Call for Abstract

Scientific Program

9th World Drug Delivery Summit, will be organized around the theme “Next generation advancements in Drug Delivery Systems”

Drug Delivery 2016 is comprised of 16 tracks and 158 sessions designed to offer comprehensive sessions that address current issues in Drug Delivery 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 1:Drug Delivery Technology

Drug Delivery Conferences attains greater global significance as Drug Delivery plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics like Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. In vitro & in vivo dissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. Pharmacokinetic behavior in drug design and development for safety issues arising either as a result of animal toxicity testing or in the clinical program itself.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 1-1Versatile Polymers
  • Track 1-2PH & Temperature sensitive
  • Track 1-3self-microemulsifying drug delivery systems (SMEDDSs)
  • Track 1-4Micronization Techniques
  • Track 1-5Osmotics Micro Pumps
  • Track 1-6Nanoencapsulate and Microencapsulate
  • Track 1-7Freeze Dried
  • Track 1-8Disintegrating Agents
  • Track 1-9Advances in GRDDS
  • Track 1-10Dynamic invitro-invivo studies
  • Track 1-11Drug design and development
  • Track 1-12Solid Dispersion
  • Track 1-13Delivery of Therapeutic Gases

Track 2:Novel Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery via Novel techniques for formulation development, Drug Delivery conference themed quality topics on Liposomes, Dendrimer, Targeted Drug Delivery design, versatile polymer in Drug Delivery and Controlled Drug Delivery, Trans mucosal Drug Delivery, Optimization of pharmaceutical products, Sustained Drug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development and medicinal chemistry.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2016, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 2-1Local Drug Delivery Systems
  • Track 2-2Sustained Drug Delivery Systems
  • Track 2-3Liposomes Drug Delivery Systems
  • Track 2-4Modified Drug Delivery Systems
  • Track 2-5Targeted Drug Delivery Systems
  • Track 2-6Transmucosal Drug Delivery Systems
  • Track 2-7Ocular Drug Delivery Systems
  • Track 2-8Controlled Drug Delivery Systems
  • Track 2-9Dentrimer Drug Delivery Systems
  • Track 2-10Nanoparticulate Drug Delivery Systems
  • Track 2-11Transdermal Drug Delivery Systems
  • Track 2-12Magnetically Induced Drug Delivery System
  • Track 2-13Intracellular Drug Delivery Systems
  • Track 2-14Blood Brain Barrier Delivery Systems

Track 3:Routes of Drug Administration

Aimed and specially designed session for young and senior researcher from academic on Novel routes in drug delivery where researcher interested for developing novel routes to minimize side effects for common routes by which a drug is brought into contact with the body session includes different routes of administration like Topical drug delivery via a large range of classes including but not limited to creams, foams, gels, lotions, and ointments. Pulmonary mode of drug delivery system route is gaining much importance in the present day research field as it enables to target the drug delivery directly to lung both for local and systemic treatment. Nasal drug delivery an alternative route restricted to intravenous administration this area has been widely investigated in recent years by academics. Topics like other novel routes wise Vaginal drug delivery covers self-insertion creams, foams, gels, irrigations and tablets, are known to reside in the vaginal cavity. Oral Drug Delivery routes to reaching different parts of the body via the bloodstream. Injectable formulations intended for administration by injection, infusion or implantation into the body.

The market is categorized on the basis of route of administration, end user, and region. The route of administration market is further segmented into oral, pulmonary, ocular, nasal, topical, injectable, implantable and transmucosal drug delivery technology. The topical drug delivery technology market segment is expected to witness the highest CAGR in the forecast period.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 3-1Oral drug delivery routes
  • Track 3-2Intranasal drug delivery
  • Track 3-3Tropical drug delivery
  • Track 3-4Ocular drug delivery
  • Track 3-5Parentral routes
  • Track 3-6vaginal route
  • Track 3-7Buccal routes
  • Track 3-8Pulmonary Delivery of Antibiotics
  • Track 3-9Pulsitile Routes

Track 4:Pharmaceutical Nanotechnology

Pharmaceutical Nano technology session includes Drug Delivery using Nanotechnology, Nanoparticles permeability to BBB, Nanoparticles application, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarriers. Carriers for nanotechnology, Nanomedicine, magnetic nanoparticles. In this review Polymer Nanotechnology for Drug Delivery, Nano composite materials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 
  • Track 4-1Challenges and advances in nanotechnology
  • Track 4-2Solid self-nanoemulsifying drug delivery system (S-SNEDDS)
  • Track 4-3Nanotechnology from the bench to Scale up
  • Track 4-4Nanomedicine
  • Track 4-5Nanotechnology for lung diseases
  • Track 4-6Nanoparticles permeability to BBB
  • Track 4-7Nanoparticles application
  • Track 4-8Nanoliposome-mediated delivery
  • Track 4-9Coated Gold Nanoparticles
  • Track 4-10Silk fibroin nanoparticle
  • Track 4-11Future aspects of Pharmaceutical Nanotechnology
  • Track 4-12Nanotechnology for Targeted siRNA Delivery

Track 5:Nucleic Acid Based Drug Delivery

Nucleic acids science and technologies experience tremendous progress and changes. The conference will feature prominent experts discussing latest advances in nucleic acids research and development: TNA for treating cancer and viral diseases in the near future for Drug Delivery includes Novel RNAi-Based Therapy, advances in siRNA delivery, oligonucleotide drug delivery, viral gene therapy and Artificial microRNAs, non-coding RNA (miRNA, piRNA, lncRNA, and lincRNA) this architect session to play an important role in the fields of cancer targeting and pharmaceutical nanotechnology.

The RNAi nucleic acid drug delivery market was worth $169.1 million globally in 2012 and by 2017 it is estimated the market will have matured. By 2017, the market for RNAi drug delivery could be around $1.1 billion globally, reflecting a compound annual growth rate (CAGR) of 45%.

  • Track 5-1Novel RNAi-Based Therapy
  • Track 5-2Viral gene therapy
  • Track 5-3Aptamer and Antisense
  • Track 5-4Drug target miRNAs
  • Track 5-5MicroRNA Technology
  • Track 5-6Cancer-targeted MDR-1 siRNA delivery
  • Track 5-7Importing from DNA Nanotechnology
  • Track 5-8Formulation strategy for siRNA delivery
  • Track 5-9Oligonucleotide Drug Delivery
  • Track 5-10Nanotechnologies Relevant to RNA Research
  • Track 5-11Strategies for siRNA delivery
  • Track 5-12Nanoimmuology and RNA Nanotechnology
  • Track 5-13Extracellular RNA for Biomarker Development

Track 6:Smart Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery via smart polymers, Smart Drug Delivery conference themed quality topics on Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.
 
Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 

  • Track 6-1Novel pharmaceutical ingredients
  • Track 6-2Delivery through Versatile polymers
  • Track 6-3Ultrasound Mediated Drug Delivery System
  • Track 6-4Hydrogel in Drug Delivery
  • Track 6-5Emulgel Drug Delivery
  • Track 6-6Micelle Drug Delivery
  • Track 6-7Insitu Drug Delivery
  • Track 6-8Lymphoid Drug Delivery System
  • Track 6-9Sonophoresis Drug Delivery System
  • Track 6-10Mucosal Drug Delivery System
  • Track 6-11Microsponge Drug Delivery System

Track 7:Vaccine Design and Delivery Technology

Vaccine Drug Delivery are multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies, this session includes Laser technology for Vaccine Delivery, Challenges and opportunities For Vaccine Delivery These advances promise to accelerate the development and testing Jet injectors, micro needles, Needle free drug delivery technology, is an innovative technique to deliver drugs into a person's body without piercing their skin.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 7-1New Horizons in Vaccine Drug Delivery
  • Track 7-2Challenges and opportunities For Vaccine Delivery
  • Track 7-3Needle-free delivery
  • Track 7-4Vaccines for cancer chemotherapy
  • Track 7-5Immunostimulatory systems
  • Track 7-6Jet injectors and microneedles
  • Track 7-7Self-Amplifying mRNA Vaccines

Track 8:Drug Delivery Companies and Markets

In today's health care industry Drug Delivery has become key in pharmaceutical product development. New innovative technologies that include inhalation, Oral, Rectal, Sublungal, and Vaginal systems that fully bioresorbable polymers allow for increased performance of new and existing pharmaceutical compounds to deliver Drug.

Patients will benefit from the enhanced efficacy of pharmaceutical products and from reduction of side-effects.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 

  • Track 8-1Drug Delivery Market Research
  • Track 8-2Generic Drug Manufacturer
  • Track 8-3Drug Delivery Device Company
  • Track 8-4Drug Delivery Pharmaceutical Companies
  • Track 8-5Contract Drug Delivery Companies
  • Track 8-6Commercial Manufacturing

Track 9:Novel Bio therapeutics and Drug Delivery Systems

The demand for biotherapeutics is continuously increasing, because many biopharmaceutical drugs are reaching later stage clinical trials. Most biotherapeutic drugs are recombinant monoclonal antibodies which are widely produced in mammalian cell lines because of the need for post-translational modifications that should be alike or at least similar to those obtained in humans. Thus, there is an increase in the market for cell line development. Moreover, advancements in upstream processing technologies have led to improvement in speed and efficiency of generating robust and highly productive cell line for large scale production of protein therapeutics and has propelled the market for cell line development.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza,  Zoladex, Beckton Dickinson & Company (U.S.), Beckman Coulter (U.S.), Boehringer Ingelheim Group (Germany), Catalent Inc. (U.S.), CMC Biologics A/S (Denmark), Lonza Group Ltd. (Switzerland), EMD Millipore (U.S.), Partec (Sysmex Corporation) (Japan), ProBioGen AG (Germany), Selexis SA (Germany), Sigma-Aldrich Co. LLC. (U.S.), Sony Biotechnology Inc. (U.S.), and Thermo Fisher Scientific Inc. (U.S.)

According to a New Market Research “Bio therapeutics as Novel Technique in Drug Delivery  - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022”, the Bio therapeutics as Novel Technique in Drug Delivery  was valued at US$56.03 mn in 2015 and is anticipated to expand at a CAGR of 7.5% from 2015 to 2022 to reach US$99.84 mn by 2022.

 

  • Track 9-1Biotherapeutics formulations
  • Track 9-2Biotherapeutics Technique in Drug Delivery
  • Track 9-3Nonclinical toxicology testing strategies
  • Track 9-4Stability of Pharmaceutical products
  • Track 9-5Advances in computational modeling for bioavailability
  • Track 9-6Recent Developments in QBD
  • Track 9-7Services for the Pharmaceutical Industry
  • Track 9-8CRO – Contract Research Organisations

Track 10:Drug Delivery and Device Development

In this session we will focus on devices designed for drug delivery through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured.  Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care.
 
To change that perception, the FDA last year announced $40 million to a new Medical Device Innovation Consortium (MDIC) charged with simplifying the process of designing and testing new technologies. With input from industry, government, and other nonprofit organizations, public-private MDIC will prioritize the regulatory science needs of the medical device community and fund projects to streamline the process.
 
Current research on femtosecond laser microfabrication of fluidic devices is introduced to present their research to elaborate. The research on microfluidics provides highly sensitive microfluidic sensors for practical applications with significant advantages of portability, efficiency, sensitivity, versatility, and low cost.
  • Track 10-1Emerging Medical Devices
  • Track 10-2surgical sutures
  • Track 10-3Contact Lenses
  • Track 10-4smart polymers in medical devices
  • Track 10-5Devices for Paediatric medicines
  • Track 10-6Contraceptions
  • Track 10-7Lancets
  • Track 10-8Emerging Medical Devices
  • Track 10-9Contact Lens
  • Track 10-10BioMEMS in Drug Delivery
  • Track 10-11Controlled Release Devices for Drug Delivery
  • Track 10-12ENT Medical Devices

Track 11:Recent Advances in Drug Delivery

The scope of this session on research in Recent Advances in Drug Delivery includes
 
Opportunities and challenges for Drug Delivery Market in the pharmaceuticals industry
Market revenues and forecasts for Drug Delivery Market in the global pharmaceutical industry from 2009 to 2025
The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China
Technology trends in Drug Delivery Market that shape the industry
Qualitative analysis of the market drivers, barriers, future outlook and challenges for the Oral Drug Delivery Market Analysis of competitive landscape and the leading market players
  • Track 11-1solid pharmaceutical dosage forms
  • Track 11-2 Improve drug bioavailability
  • Track 11-3CNS targeted drug delivery
  • Track 11-4Tumor targeting
  • Track 11-5Biopolymers
  • Track 11-6Pro-drugs as novel drug delivery systems
  • Track 11-7Cancer biomarkers
  • Track 11-8coating materials
  • Track 11-9Bioabsorbable intelligent
  • Track 11-10Pro-drugs delivery

Track 12:Major Challenges in Drug Delivery

By focusing on challenges and opportunities in the drug-delivery technology market there is an increasing demand for effective and, ideally, non-invasive drug-delivery methods. This is especially the case for the biopharmaceutical sector, which has experienced an overwhelming growth due to advances in biotechnology. In 2009, over $12 billion were invested in biologics / biotechnology research and development (R&D), representing a 26% share in the total R&D expenditure. A recent report by the Pharmaceutical Research and Manufacturers of America (PhRMA) states that in 2015 there were 901 biological in development, targeting more than 100 diseases.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 

  • Track 12-1Reducing Patient Compliance
  • Track 12-2Drug Delivery of poorly soluble drugs
  • Track 12-3self-emulsifying drug delivery systems (SEDDS)
  • Track 12-4Overcoming challenges in pediatric drug delivery
  • Track 12-5Controlling the addictive nature of drugs
  • Track 12-6Polymeric enhancement

Track 13:Peptide and Protein Drug Delivery

This session and track is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 13-1Controlled release system for Protein Delivery
  • Track 13-2Polymers for delivery of proteins
  • Track 13-3Nanotechnology for Protein Delivery
  • Track 13-4Nanochannels for Protein Delivery
  • Track 13-5Chitosan derivatives for Protein Delivery
  • Track 13-6Novel system for specific Protein Delivery
  • Track 13-7 Release of Proteins from Polymers
  • Track 13-8Protein Delivery from Microspheres
  • Track 13-9Peptidal drug delivery
  • Track 13-10Peptide therapeutics
  • Track 13-11Cell-penetrating and cell-targeting

Track 14:Drug Delivery Equipments and Machinery

Equipment and Machinery for Drug Delivery session includes major area participants/ Vendors, Engineers in Equipments from Laboratory equipments, Analytical Equipments, Auto Injectors, Semi-Automatic R&D Equipment, Large volume Production Machineries and Drug Delivery Pilot Equipments.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 14-1Laboratory equipments
  • Track 14-2Designs in Equipments
  • Track 14-3Auto Injectors
  • Track 14-4Pen Injectors
  • Track 14-5Semi Automatic R&D Equipments
  • Track 14-6Efficiency and Repeatability
  • Track 14-7Wire Less Equipments
  • Track 14-8Compliance and International Standards
  • Track 14-9Analytical Equipments
  • Track 14-10Large volume Production Machinaries
  • Track 14-11Latest Innovations and Advancements
  • Track 14-12Twin-Screw Granulation
  • Track 14-13Spheronization
  • Track 14-14Drug Delivery Pilot Equipments

Track 15:Business Opportunities in Drug Delivery

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug delivery.
  • Track 15-1Consistent quality
  • Track 15-2Production performance and continuity of supply
  • Track 15-3Product and technology auditing and due diligence
  • Track 15-4Regulatory Issues, quality control, and business development
  • Track 15-5Bussiness opportunities in drug delivery
  • Track 15-6competitive costs of product

Track 16:Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.